Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lavy

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Clinical and Experimental Immunology|April 8, 2015
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trialE Israeli, E Goldin, S Fishman, et al.
Gastroenterology|May 1, 1996
Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trialR Oren, N Arber, S Odes, et al.
The American Journal of Gastroenterology|April 9, 2015
Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trialR Oren, M Moshkowitz, S Odes, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditisV Gross, S Bar-Meir, A Lavy, et al.
The American Journal of Gastroenterology|December 17, 1997
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trialR Oren, M Moshkowitz, S Odes, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Clinical and Experimental Immunology|April 8, 2015
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trialE Israeli, E Goldin, S Fishman, et al.
Gastroenterology|May 1, 1996
Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trialR Oren, N Arber, S Odes, et al.
The American Journal of Gastroenterology|April 9, 2015
Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trialR Oren, M Moshkowitz, S Odes, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditisV Gross, S Bar-Meir, A Lavy, et al.
The American Journal of Gastroenterology|December 17, 1997
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trialR Oren, M Moshkowitz, S Odes, et al.
Pageof 9